Smart nanomedicine agents for cancer, triggered by pH, glutathione, H(2)O(2), or H(2)S

Effective tumor diagnosis and therapy have always been a significant but challenging issue. Although nanomedicine has shown great potential for improving the outcomes of tumor diagnosis and therapy, the nonspecial targeted distribution of nanomedicine agents in the whole body causes a low diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yaping, An, Lu, Lin, Jiaomin, Tian, Qiwei, Yang, Shiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664425/
https://www.ncbi.nlm.nih.gov/pubmed/31440046
http://dx.doi.org/10.2147/IJN.S210116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664425/
https://www.ncbi.nlm.nih.gov/pubmed/31440046
http://dx.doi.org/10.2147/IJN.S210116

Ejemplares similares